Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo

Current understanding suggests that malignant stem and progenitor cells must be reduced or eliminated for prolonged remissions in myeloid neoplasms such as acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). Multicolor flow cytometry has been widely used to distinguish stem and myelo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Knorr, Katherine L.B., Finn, Laura E., Smith, B. Douglas, Hess, Allan D., Foran, James M., Karp, Judith E., Kaufmann, Scott H.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Translational Research Articles and Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5442784/
https://ncbi.nlm.nih.gov/pubmed/28297583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2016-0034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars